BACTOLIFE

BACTOLIFE

Private
Copenhagen, Capital Region of DenmarkHealthcare & Life Scienceshttps://www.bactolife.com

Last Round

Series B

Jan 6, 2026

Est. Valuation

$23.26M

Total Funding Raised

$81.4M

Momentum Score

50 /100

Company Overview

Bactolife is a biotechnology company that develops proprietary Binding Protein ingredients to enhance gut microbiome health and mitigate gastrointestinal infections in both humans and animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

binding proteinsgut healthprecision fermentationanimal healthantimicrobial resistanceAMRantibiotic alternativesfunctional food ingredientsmicrobiome therapeuticspostbioticsanimal feed ingredientseubioticsB2B ingredientspathogen neutralizationlivestock health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BACTOLIFE Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BACTOLIFE Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BJan 6, 2026
Series AAug 8, 2023
GrantAug 30, 2022
SeedApr 19, 2021

Key People

Founding team and executive leadership

Andreas Laustsen-Kiel

Co-Founder & CTO

Founding Team

Jens Møller Nielsen

Chief Operating Officer

Executive Team

Thomas Gadegaard

Chief Financial Officer, Senior Vice President Finance

Executive Team

BACTOLIFE Investors

Notable investors and investment history

InvestorRounds
SelfinvestSeed, Series A
Athos KGSeries B, Series A
Gates Family FoundationSeries B
Gates FoundationSeries B
Novo HoldingsSeries B, Series A, Seed
The Bill & Melinda Gates Foundation TrustGrant, Series A
NovoseedsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2027

    Binding Proteins product to target mass market from 2027.

  • Jan 8, 2026

    Partnering with AceBiome to launch a new probiotic-binding protein product in Korea.

BACTOLIFE Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BACTOLIFE Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BACTOLIFE's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen, Capital Region of Denmark
Employee Range69
Year Founded2017
Last FundingJan 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.